Dr Susan Galbraith at ESMO 2014: The ‘National Lung Matrix' trial – a new strategy for cancer drug research and development

Dr Susan Galbraith at ESMO 2014: The ‘National Lung Matrix' trial – a new strategy for cancer drug research and development

EMJ

5 years
426 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the European Society for Medical Oncology (ESMO) 2014 Congress, Dr Susan Galbraith (Vice-President Oncology, AstraZeneca) discusses the National Lung Matrix trial, which is a collaboration between Cancer Research UK, AstraZeneca and Pfizer. This approach aims to improve the interaction between academia and industry, thereby facilitating the development of molecularly defined treatments in lung cancer.
Up Next Autoplay